New Zealand markets closed

Bausch Health Companies Inc. (BHC)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
8.60-0.06 (-0.69%)
At close: 04:00PM EDT
8.60 -0.00 (-0.02%)
After hours: 05:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.15B
Enterprise value 24.59B
Trailing P/E N/A
Forward P/E 2.38
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.36
Price/book (mrq)N/A
Enterprise value/revenue 2.81
Enterprise value/EBITDA 11.17

Trading information

Stock price history

Beta (5Y monthly) 0.86
52-week change 311.69%
S&P500 52-week change 321.23%
52-week high 311.46
52-week low 35.57
50-day moving average 39.22
200-day moving average 38.29

Share statistics

Avg vol (3-month) 32.76M
Avg vol (10-day) 34.78M
Shares outstanding 5366.67M
Implied shares outstanding 6367.28M
Float 8303.99M
% held by insiders 10.91%
% held by institutions 179.55%
Shares short (28 Mar 2024) 422.5M
Short ratio (28 Mar 2024) 49.91
Short % of float (28 Mar 2024) 48.13%
Short % of shares outstanding (28 Mar 2024) 46.14%
Shares short (prior month 29 Feb 2024) 424.64M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 46.52
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 410 Nov 2010
Last split factor 22:1
Last split date 316 Oct 2000

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -6.76%
Operating margin (ttm)21.06%

Management effectiveness

Return on assets (ttm)3.82%
Return on equity (ttm)-686.52%

Income statement

Revenue (ttm)8.76B
Revenue per share (ttm)24.00
Quarterly revenue growth (yoy)9.80%
Gross profit (ttm)N/A
EBITDA 2.88B
Net income avi to common (ttm)-592M
Diluted EPS (ttm)-1.62
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)947M
Total cash per share (mrq)2.59
Total debt (mrq)22.6B
Total debt/equity (mrq)N/A
Current ratio (mrq)1.30
Book value per share (mrq)-2.80

Cash flow statement

Operating cash flow (ttm)1.03B
Levered free cash flow (ttm)738.12M